Dr. Allsopp has over 20 years experience in the biology of aging field and stem cell biology field. He began his research training at McMaster University, Canada, where he obtained his Ph.D. degree. As a graduate student, he was among a small group of researchers to first associate telomere shortening with cell senescence. During his graduate work and subsequent post doctoral fellowship, he also performed telomere and telomerase research at Geron Corporation, one of the first aging biotech companies in the US. Following time at Geron Corp, he continued on with post doctoral research at Stanford University, studying the role of telomerase in hematopoietic stem cells during aging in mice. He then transitioned to a faculty position at the Institute for Biogenesis Research, University of Hawaii where he continued to study the regulation of telomerase in stem cells. In 2010 he began a collaboration with Dr. Brad Willcox to study the mechanism underlying the robust healthspan enhancing effect of the FOXO3 gene in humans. Dr. Allsopp has published his research in prestigious journals including Science, Nature Medicine and PNAS. He has been an investigator on several grants from the NIH, including co-director of an NIH P20 center grant on translational research in aging. He recently transitioned to a faculty position in the College of Medicine at Alfaisal University.